PRESS RELEASE published on 01/30/2023 at 14:30, 3 years 1 month ago Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise
PRESS RELEASE published on 01/27/2023 at 22:15, 3 years 1 month ago Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRESS RELEASE published on 01/26/2023 at 14:30, 3 years 1 month ago Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe
PRESS RELEASE published on 01/25/2023 at 14:30, 3 years 1 month ago Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer
PRESS RELEASE published on 01/23/2023 at 14:30, 3 years 1 month ago Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences
PRESS RELEASE published on 01/20/2023 at 18:45, 3 years 1 month ago Jaguar Health Reports Voting Results from January 2023 Special Meeting of Stockholders
PRESS RELEASE published on 01/20/2023 at 14:30, 3 years 1 month ago Jaguar Health to Present at Lytham Partners Investor Select Conference on January 31st
PRESS RELEASE published on 01/12/2023 at 01:10, 3 years 2 months ago REMINDER: Jaguar Health to Hold Investor Webcast Thursday, January 12th at 10:30 AM EST to Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Jaguar’s Mental Health Entheogen Therapeutics Initiative (ETI) to Discover Novel Therapies Der
PRESS RELEASE published on 01/11/2023 at 14:30, 3 years 2 months ago Sandra M. Swain, MD, FACP, FASCO Joins Jaguar Health's Scientific Advisory Board
PRESS RELEASE published on 01/10/2023 at 14:45, 3 years 2 months ago Jaguar Health to Hold Investor Webcast Thursday, January 12th at 10:30 AM EST to Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Jaguar's Mental Health Entheogen Therapeutics Initiative (ETI) to Discover Novel Therapies Derived from Ps
Published on 03/11/2026 at 23:00, 10 hours 26 minutes ago Redwood AI Enhances Its Chemical Synthesis Platform with Industry-Grade Integrated Safety Functionality, Streamlining User Chemical Development Processes
Published on 03/11/2026 at 22:55, 10 hours 31 minutes ago Pathfinder Ventures Announces Closing of Parksville Refinancing and Extension of Private Placement
Published on 03/11/2026 at 19:00, 14 hours 26 minutes ago Worksport Announces Fourth Quarter and Full Year 2025 Earnings Date; Updated Financial Guidance and Path to Cash-Flow Positivity to Be Discussed
Published on 03/12/2026 at 09:05, 21 minutes ago Nordic Semiconductor launches lifetime flat-rate FOTA solution, readying customers for Cyber Resilience Act
Published on 03/12/2026 at 09:00, 25 minutes ago SBF AG expects positive market signals from KRITIS umbrella act for critical infrastructure protection
Published on 03/12/2026 at 09:00, 25 minutes ago Original-Research: Deutsche Beteiligungs AG (von NuWays AG): BUY
Published on 03/12/2026 at 09:00, 26 minutes ago Mitsubishi UFJ Securities International Plc - Removal
Published on 03/12/2026 at 08:30, 56 minutes ago Claude Bernard lance Claude Bernard Compléments alimentaires en partenariat avec Synadiet
Published on 03/12/2026 at 07:30, 1 hour 56 minutes ago Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics
Published on 03/12/2026 at 07:30, 1 hour 56 minutes ago Biophytis et LynxKite renforcent leur alliance pour accélérer la découverte de médicaments dédiés à la longévité grâce à l’IA
Published on 03/11/2026 at 20:05, 13 hours 21 minutes ago CDA - Compte rendu de l'AG et du Conseil d'administration
Published on 03/11/2026 at 18:30, 14 hours 55 minutes ago Filing of the 2025 TF1 Universal Registration Document
